A
Ansun BioPharma
Developing innovative therapeutics to address unmet medical needs in cancer and viral infections
About Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company based in San Diego, CA, specializing in the development of immuno-biologic therapies aimed at preventing and treating life-threatening diseases. The company focuses on creating safe and effective treatments for the most vulnerable patient populations, including those with compromised immune systems. Ansun BioPharma operates primarily in the biopharmaceutical market, targeting severe viral infections such as parainfluenza virus (PIV) and severe influenza.
The company's business model revolves around the research, development, and clinical trials of its proprietary therapies. Ansun BioPharma is currently enrolling patients in a Phase 3 clinical trial for DAS181, a treatment for PIV infection in immunocompromised patients, and is planning an international Phase IIb clinical trial for DAS181 for the treatment of severe influenza in hospitalized patients. The company generates revenue through funding from clinical trials, partnerships, and potential future sales of its therapies upon regulatory approval.
Source: Dealroom company dataNews
Open roles
Ansun BioPharma in the San Diego ecosystem
The Ansun BioPharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
- SCSinopharm Capital
Lilly Asia Ventures- SFSinopharm Healthcare Fund
Korea Investment Partners
Oceanpine Capital
Matrix Partners China
Junson Capital
3E Bioventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ansun BioPharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ansun BioPharma on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


